MarketCapTrends
BMRN
Biomarin Pharmaceutical Inc. (BMRN)
NASDAQ · Healthcare

Biomarin Pharmaceutical Inc. Cash on Hand 2008–2025

Biomarin Pharmaceutical Inc. annual/quarterly cash on hand history from 2009 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Biomarin Pharmaceutical Inc. cash on hand for the quarter ending December 31, 2025 were 1.31B, a 39.12% increase year-over-year.
  • Biomarin Pharmaceutical Inc. cash on hand for 2025 were 1.31B, a 39.12% increase from 2024.
  • Biomarin Pharmaceutical Inc. cash on hand for 2024 were 942.8M, a 24.86% increase from 2023.
  • Biomarin Pharmaceutical Inc. cash on hand for 2023 were 755.1M, a 4.22% increase from 2022.
  • Biomarin Pharmaceutical Inc. cash on hand for 2022 were 724.5M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Biomarin Pharmaceutical Inc. Annual Cash on Hand (Millions of US $)
2025$1,312
2024$943
2023$755
2022$725
2021$587
2020$649
2019$437
2018$494
2017$598
2016$408
2015$397
2014$875
2013$569
2012$181
2011$46
Biomarin Pharmaceutical Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$1,312
2024-12-31$943
2023-12-31$755
2022-12-31$725
2021-12-31$587
2020-12-31$649
2019-12-31$437
2018-12-31$494
2017-12-31$598
2016-12-31$408
2015-12-31$397
2014-12-31$875
2013-12-31$569
2012-12-31$181
2011-12-31$46
2010-12-31$88
2009-12-31$167

Biomarin Pharmaceutical Inc. Cash on Hand — FAQ

Biomarin Pharmaceutical Inc. (BMRN) cash on hand over the last 18 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see BMRN's cash on hand history?

The chart and table above show Biomarin Pharmaceutical Inc.'s cash on hand by year and by quarter, including the growth rate.